<DOC>
	<DOCNO>NCT02186977</DOCNO>
	<brief_summary>A proof concept ( POC ) study conduct 44 volunteer fully vaccinate hepatitis B past ( least 5 year ago ) ass safety immunogenicity intradermal vaccination hepatitis B surface vaccine antigen use newly develop intradermal injection device VAX-ID , compare intramuscular intradermal ( Mantoux technique ) injection .</brief_summary>
	<brief_title>Proof Of Concept : Immunogenicity Safety hepB Injection Dermis Using VAX-ID</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>healthy adult , check anamnestically ( base medical history ) entry study 1835 year vaccination status : fully vaccinate hepatitis B least 5 year ago , proof vaccine response ( avoid nonresponse among subject ) . Subjects ask document proof service occupational medicine University Antwerp . capable understanding , read write Dutch vaccination ( ) 4 week study onset pregnancy lactation ( woman question anamnesis ) plan vaccination study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>immunogenicity</keyword>
	<keyword>safety</keyword>
	<keyword>proof concept</keyword>
</DOC>